Approved treatments for osteoporosis and what's in the pipeline

Stacy Davis, Alok Sachdeva, Bruce Goeckeritz, Alyce M. Oliver

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Along with the release of revised guidelines, several pharmacological therapies have become available or are under investigation to help improve outcomes in patients with osteoporosis. Lifestyle modifications have been shown to be useful in osteoporosis management, and the use of medications associated with the risk of osteoporosis should be minimized. Adherence to therapy remains a challenge. Continued research and the development of additional diagnostic and therapeutic modalities are needed.

Original languageEnglish (US)
Pages (from-to)121-124
Number of pages4
JournalDrug Benefit Trends
Volume22
Issue number4
StatePublished - May 1 2010

Fingerprint

Osteoporosis
Life Style
Therapeutics
Pharmacology
Guidelines
Research

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Cite this

Davis, S., Sachdeva, A., Goeckeritz, B., & Oliver, A. M. (2010). Approved treatments for osteoporosis and what's in the pipeline. Drug Benefit Trends, 22(4), 121-124.

Approved treatments for osteoporosis and what's in the pipeline. / Davis, Stacy; Sachdeva, Alok; Goeckeritz, Bruce; Oliver, Alyce M.

In: Drug Benefit Trends, Vol. 22, No. 4, 01.05.2010, p. 121-124.

Research output: Contribution to journalArticle

Davis, S, Sachdeva, A, Goeckeritz, B & Oliver, AM 2010, 'Approved treatments for osteoporosis and what's in the pipeline', Drug Benefit Trends, vol. 22, no. 4, pp. 121-124.
Davis S, Sachdeva A, Goeckeritz B, Oliver AM. Approved treatments for osteoporosis and what's in the pipeline. Drug Benefit Trends. 2010 May 1;22(4):121-124.
Davis, Stacy ; Sachdeva, Alok ; Goeckeritz, Bruce ; Oliver, Alyce M. / Approved treatments for osteoporosis and what's in the pipeline. In: Drug Benefit Trends. 2010 ; Vol. 22, No. 4. pp. 121-124.
@article{512c772f6d4a410491e1253d905d01a0,
title = "Approved treatments for osteoporosis and what's in the pipeline",
abstract = "Along with the release of revised guidelines, several pharmacological therapies have become available or are under investigation to help improve outcomes in patients with osteoporosis. Lifestyle modifications have been shown to be useful in osteoporosis management, and the use of medications associated with the risk of osteoporosis should be minimized. Adherence to therapy remains a challenge. Continued research and the development of additional diagnostic and therapeutic modalities are needed.",
author = "Stacy Davis and Alok Sachdeva and Bruce Goeckeritz and Oliver, {Alyce M.}",
year = "2010",
month = "5",
day = "1",
language = "English (US)",
volume = "22",
pages = "121--124",
journal = "Drug Benefit Trends",
issn = "1080-5826",
publisher = "Cliggott Publishing Co.",
number = "4",

}

TY - JOUR

T1 - Approved treatments for osteoporosis and what's in the pipeline

AU - Davis, Stacy

AU - Sachdeva, Alok

AU - Goeckeritz, Bruce

AU - Oliver, Alyce M.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Along with the release of revised guidelines, several pharmacological therapies have become available or are under investigation to help improve outcomes in patients with osteoporosis. Lifestyle modifications have been shown to be useful in osteoporosis management, and the use of medications associated with the risk of osteoporosis should be minimized. Adherence to therapy remains a challenge. Continued research and the development of additional diagnostic and therapeutic modalities are needed.

AB - Along with the release of revised guidelines, several pharmacological therapies have become available or are under investigation to help improve outcomes in patients with osteoporosis. Lifestyle modifications have been shown to be useful in osteoporosis management, and the use of medications associated with the risk of osteoporosis should be minimized. Adherence to therapy remains a challenge. Continued research and the development of additional diagnostic and therapeutic modalities are needed.

UR - http://www.scopus.com/inward/record.url?scp=77953549581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953549581&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 121

EP - 124

JO - Drug Benefit Trends

JF - Drug Benefit Trends

SN - 1080-5826

IS - 4

ER -